S&W Seed Company

For Q3 fiscal 2025, S&W reported revenue of $9.5 million versus $9.4 million in Q3 last year, excluding Australia. Gross profit margin was 37.7% versus 24.6% a year ago, and adjusted EBITDA was positive $244,000 compared with negative $2.2 million last year. On the operating line, total operating expenses were $4.3 million versus $5.5 million, and adjusted operating expenses were $3.5 million versus $4.7 million. For the full year, management cut revenue guidance to $29 million to $31 million from $34.5 million to $38 million and lowered adjusted EBITDA guidance to negative $8.5 million to negative $7 million, citing tariff-related demand disruption, lower acres planted, and weaker seed purchases. Management also said full-year gross margins are expected to be approximately 30%.

Mark Herrmann framed the quarter as a mix of internal progress and external disruption. He said the company has repositioned around Americas-based, high-margin sorghum traits, highlighted the completion of the Australia VA process, the new $25 million working capital facility, and cost cuts that improved gross margin and reduced expenses. His tone was optimistic on the long term, saying Double Team and Prussic Acid Free are gaining customer response and that international expansion should eventually mirror the U.S. opportunity, even though tariffs are hurting near-term results.

Vanessa Baughman focused on the detailed drivers behind the quarter and the guidance reset. She noted Q3 revenue of $9.5 million, gross margin of 37.7%, adjusted EBITDA of $244,000, and operating expenses of $4.3 million, then explained that the full-year outlook was cut because tariffs are reducing expected acres and seed purchases, especially in Double Team, which she said is the biggest margin hit. She also pointed to inventory improvement, with inventory down to $16.9 million from $22.6 million at June 30 excluding Australia, $1 million spent supporting the VA process, $1.6 million of availability under the borrowing base, and a working capital facility of $25 million.

Analysts focused on how recent China tariff developments might affect the Q4 outlook and whether the strategic review had been altered by the uncertainty. Management said the situation is fluid, that China’s reduced buying has created elevated basis and oversupply in the U.S. grain system, but they believe the market can normalize if orders resume; they also said the strategic review is still moving forward with no completed transaction. Another question asked whether S&W can accelerate international Double Team commercialization; management said the model relies on partnerships, licensing, trait introgression, and herbicide registrations that take time, so acceleration is limited but the opportunity remains attractive. A webcast question also asked about camelina and SAF, and management said VBO’s camelina platform is progressing well, supported by an exclusive herbicide position and ongoing grower trials.